These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19276661)
21. Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma. Kamal M; Shaaban AM; Zhang L; Walker C; Gray S; Thakker N; Toomes C; Speirs V; Bell SM Breast Cancer Res Treat; 2010 Jun; 121(3):555-63. PubMed ID: 19669408 [TBL] [Abstract][Full Text] [Related]
22. NAV3 copy number changes and target genes in basal and squamous cell cancers. Maliniemi P; Carlsson E; Kaukola A; Ovaska K; Niiranen K; Saksela O; Jeskanen L; Hautaniemi S; Ranki A Exp Dermatol; 2011 Nov; 20(11):926-31. PubMed ID: 21995814 [TBL] [Abstract][Full Text] [Related]
23. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844 [TBL] [Abstract][Full Text] [Related]
24. Relationship between cytogenetic aberrations by CGH coupled with tissue microdissection and DNA ploidy by laser scanning cytometry in head and neck squamous cell carcinoma. Hashimoto Y; Oga A; Okami K; Imate Y; Yamashita Y; Sasaki K Cytometry; 2000 Jun; 40(2):161-6. PubMed ID: 10805936 [TBL] [Abstract][Full Text] [Related]
25. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476 [TBL] [Abstract][Full Text] [Related]
26. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas. Roesler JM; Livingston EH; Srivatsan E; Chang P; Wang MB J Surg Res; 1998 Jun; 77(1):50-4. PubMed ID: 9698532 [TBL] [Abstract][Full Text] [Related]
27. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. Okami K; Wu L; Riggins G; Cairns P; Goggins M; Evron E; Halachmi N; Ahrendt SA; Reed AL; Hilgers W; Kern SE; Koch WM; Sidransky D; Jen J Cancer Res; 1998 Feb; 58(3):509-11. PubMed ID: 9458098 [TBL] [Abstract][Full Text] [Related]
28. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354 [TBL] [Abstract][Full Text] [Related]
29. Cytokeratin 18 expression in squamous cell carcinoma of the head and neck. Balm AJ; Hageman PC; van Doornewaard MH; Groeneveld EM; Ivanyi D Eur Arch Otorhinolaryngol; 1996; 253(4-5):227-33. PubMed ID: 8737774 [TBL] [Abstract][Full Text] [Related]
30. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Singh RB; Amare Kadam PS Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529 [TBL] [Abstract][Full Text] [Related]
31. LRIG and cancer prognosis. Lindquist D; Kvarnbrink S; Henriksson R; Hedman H Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912 [TBL] [Abstract][Full Text] [Related]
32. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas. Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004 [TBL] [Abstract][Full Text] [Related]
33. Downregulation of RAD17 in head and neck cancer. Zhao M; Begum S; Ha PK; Westra W; Califano J Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792 [TBL] [Abstract][Full Text] [Related]
34. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma. Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297 [TBL] [Abstract][Full Text] [Related]
35. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes. Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059 [TBL] [Abstract][Full Text] [Related]
36. Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations. Wemmert S; Linxweiler M; Lerner C; Bochen F; Kulas P; Linxweiler J; Smola S; Urbschat S; Wagenpfeil S; Schick B J Cancer Res Clin Oncol; 2018 Jun; 144(6):1129-1141. PubMed ID: 29560516 [TBL] [Abstract][Full Text] [Related]
37. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes. Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319 [TBL] [Abstract][Full Text] [Related]
38. A putative oncogenic role for MPP11 in head and neck squamous cell cancer. Resto VA; Caballero OL; Buta MR; Westra WH; Wu L; Westendorf JM; Jen J; Hieter P; Sidransky D Cancer Res; 2000 Oct; 60(19):5529-35. PubMed ID: 11034098 [TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis. Gasparotto D; Vukosavljevic T; Piccinin S; Barzan L; Sulfaro S; Armellin M; Boiocchi M; Maestro R Int J Cancer; 1999 Aug; 84(4):432-6. PubMed ID: 10404099 [TBL] [Abstract][Full Text] [Related]
40. Absence of ST7 gene alterations in human cancer. Dong SM; Sidransky D Clin Cancer Res; 2002 Sep; 8(9):2939-41. PubMed ID: 12231539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]